SPL

2.11%

9.3¢ starpharma holdings limited

Get ready for an explosive week, page-28

First 28 Last

Share
Profile

Follow
ThereAbouts

4,462 Posts.

343

09/03/18

10:56

Post #: 31642511
Share

Originally posted by savvyinvestor ↑

I'm finally joint the register as a SPL holder after watching last few months.
since it spiked late last year, its reassuring to see it has held onto those gains and always held support around 1.30-1.40. this is a good technical sign from my experience after a doubling in the share price, as it shows holders still have conviction to hold even after 100% profits in a short period.

as a doctor working in urology/ oncology i like the DEP technology and the results in early phase trials are impressive.

I've been held back by some cynicism around the size of the fleurstat market and the time taken to ramp up, but I'm going to take a leap of faith and hope others are right that sales will grow strongly within 12months and help finance the DEP trials.

there is a lot of M&A activity in au biotech's and global biotech's in general, so SPL is certainly a takeover target like MSB if it keeps kicking goals in phase 2 trials of DEP.

the directors are still buying which is another positive sign that the future is bright and the company is not overvalued.

i don't see any major near term catalysts for a rerate given fleurstat launch and FDA application are well known and factored in, but a new product/ partnership ann is always on the horizon. Im not looking for a quick buck here so near term catalysts don't matter too much. I'm looking for a 2-3 year investment timeframe in which to execute the DEP phase 2 trials and be planning phase 3 and build sales momentum in fleurstat. then i can see a re-rate to $3 or more, but this may well take a couple of years with ups and downs back towards $1 on the cards along the way.

I've taken a small 2% portfolio weighting with my entry parcels at 1.38, so room to add if it drops due to impatience amongst holders.

Expand

"I'm finally joint the register as a SPL holder after watching last few months."

Bit late to this one, but welcome SI, I seem to remember you unfairly copped the moniker of being a "downramper" for your recent measured and informed comments on another thread, but I'm sure you'll now be welcomed to the fold, FMD!!!, it's now even acceptable to raise doubts about St Jackie.

Edit: There could be a anther buying opportunity coming up today, I'm in with another bid and hoping for the best.

Last edited by ThereAbouts: 09/03/18

SPL Price at posting: $1.37 Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

GRX

GreenX picks up prospective copper project in Germany

DVP

Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place

Is oil undervalued?

BOE

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

VMT

Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

VMS

Venture to sniff out high-grade REE targets at Jupiter project, WA

WGX

Westgold sets its sights on top five producer status through merger with Karora

MGU

Collaboration in a green (steel) future the focus for Magnum and Saudi partners

NXG

Cost blow-out for Rook I uranium project sees share plummet for NexGen

There are more pages in this discussion • 7 more messages in this thread...

First 28 Last

Add SPL (ASX) to my watchlist

(20min delay)
Last 9.3¢		Change -0.002(2.11%)		Mkt cap ! $38.35M

Open	High	Low	Value	Volume
9.5¢	9.5¢	9.3¢	$48.64K	512.2K

Buyers (Bids)

No.	Vol.	Price($)
3	153365	9.3¢

Sellers (Offers)

Price($)	Vol.	No.
9.8¢	65000	1

View Market Depth

No.	Vol.	Price($)
3	153365	0.093
1	60000	0.092
1	5000	0.090
1	50000	0.089
2	147200	0.087

Price($)	Vol.	No.
0.098	65000	1
0.099	56700	2
0.100	111205	3
0.105	146531	5
0.110	43099	6

Last trade - 16.10pm 02/08/2024 (20 minute delay)

SPL (ASX) Chart

Get ready for an explosive week, page-28

GreenX picks up prospective copper project in Germany

Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place

Is oil undervalued?

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

Venture to sniff out high-grade REE targets at Jupiter project, WA

Westgold sets its sights on top five producer status through merger with Karora

Collaboration in a green (steel) future the focus for Magnum and Saudi partners

Cost blow-out for Rook I uranium project sees share plummet for NexGen

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Get ready for an explosive week, page-28

Top Stories

GreenX picks up prospective copper project in Germany

Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place

Is oil undervalued?

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

Venture to sniff out high-grade REE targets at Jupiter project, WA

Westgold sets its sights on top five producer status through merger with Karora

Collaboration in a green (steel) future the focus for Magnum and Saudi partners

Cost blow-out for Rook I uranium project sees share plummet for NexGen

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News